Arthroscopy - 2026-10-08 - Journal Article; Review
Biologic Graft Augmentation Is Associated With Lower Retear Rates and Greater Tendon Thickness Compared With Arthroscopic Rotator Cuff Repair Without Augmentation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Amin V, Ghayyad K, Oshikoya O, Goltz D, Huffman GR
Topics
Key Takeaway
Biologic graft augmentation in arthroscopic rotator cuff repair reduces retear rates by 69% (risk ratio 0.31) compared with repair alone across 9 RCTs.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This systematic review and meta-analysis of 9 RCTs evaluated biologic graft augmentation versus standard arthroscopic rotator cuff repair. Augmentation produced a significant reduction in retear rate (RR 0.31, 95% CI 0.22–0.45, P<0.00001) and a 1.20 mm increase in tendon thickness at final follow-up (P<0.00001). ASES and Constant scores improved significantly with augmentation, but UCLA scores did not reach significance, and heterogeneity in graft type limits interpretation.
Key Limitation
The small aggregate sample size (n=556 across 9 trials) combined with heterogeneity in graft type, tear size, and repair technique limits the ability to identify which specific biologic augment drives the observed benefit.
Original Abstract
PURPOSE
To perform a systematic review and meta-analysis of Level I and II randomized studies evaluating biologic graft augmentation in arthroscopic or arthroscopic-equivalent rotator cuff repair.
METHODS
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic literature search was conducted in PubMed, Scopus, Embase, and Cochrane databases. Randomized controlled trials comparing the use of a biologic graft augmentation in adjunct to standard arthroscopic repair were included. A minimum clinical follow-up of greater than 1 year was required for inclusion. Outcome measures included retear rate, tendon thickness, American Shoulder and Elbow Surgeons score, Constant score, and the University of California Los Angeles score. Random-effects models were used to calculate mean differences and 95% confidence intervals.
RESULTS
From our literature search, 9 randomized controlled trials consisting of 556 patients met criteria for inclusion in the meta-analysis. The use of biologic graft augmentation showed a significant reduction in retear rates (risk ratio = 0.31; confidence interval: [0.22, 0.45]; P < .00001) and a significant increase in tendon thickness at final follow-up (mean difference: 1.20 mm; confidence interval [1.14, 1.26]; P < .00001). Meta-analysis also revealed a significant increase between preoperative and postoperative American Shoulder and Elbow Surgeons and Constant score and a nonsignificant increase between preoperative and postoperative University of California Los Angeles score.
CONCLUSIONS
Biologic graft augmentation in arthroscopic or arthroscopic-equivalent rotator cuff repair was associated with lower retear rates and greater tendon thickness. Clinical outcome improvement was less consistent across reported patient-reported measures, and interpretation should account for heterogeneity in graft type and outcome reporting.
LEVEL OF EVIDENCE
Level II, systematic review and meta-analysis of Level I and II studies.